Aquestive Therapeutics, Inc. (AQST) › Total LiabilitiesAquestive Therapeutics, Inc. (AQST) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2017: $69.61M2018: $76.77M2019: $84.60M2020: $111.38M2021: $144.13M2022: $175.62M2023: $163.91M2024: $161.58M2025: $194.09M$194.09M2017Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$194.09M+20.1%2024$161.58M-1.4%2023$163.91M-6.7%2022$175.62M+21.9%2021$144.13M+29.4%2020$111.38M+31.7%2019$84.60M+10.2%2018$76.77M+10.3%2017$69.61M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share